key: cord-0965518-0tsvlya7
authors: Jain, Amit; Lamperti, Massimo; Doyle, D. John
title: COVID-19 and perioperative neurocognitive disorder and SARS-CoV-2 induced dysregulation of the renin-angiotensin system and kynurenine metabolism. Comment onBr J Anaesth 2021; S0007091221003779 [update; link]
date: 2021-11-08
journal: Br J Anaesth
DOI: 10.1016/j.bja.2021.10.031
sha: 95922e7ef851958a0b3e717e1b538747aff14a4a
doc_id: 965518
cord_uid: 0tsvlya7

nan

SARS-CoV-2 infection to induce indirect BBB injury and neuroinflammation. These have 26 also been associated with Alzheimer's disease (AD) and PND. 7

Based on the finding of increased ACE2 expression in AD brain 8 , Wei and colleagues 28 considered AD patients to have greater risk for SARS-CoV-2-induced CNS infection 1 . 29 However, this is arguable as the structure and function of ACE2 isoforms upregulated during 30 inflammation are unclear. Recent studies show that interferons and viruses induce ACE2 31 isoforms that lack angiotensin-II (Ang-II) catalytic-activity and differ from full-length SARS-32 CoV-2 receptors. 9,10 Thus, it is unclear whether interferon-gamma (INF-γ)-induced 33 upregulation of ACE2 as evident in SARS-CoV-2 infection 11 , and possibly in other 34 inflammatory situations such as AD 1,8 , increases susceptibility to SARS-CoV-2 infection.

Ding and colleagues 8 found no relationship between ACE2 upregulation and AD severity, 36 while elsewhere ACE2 downregulation in brain correlated with increased expression of 37 amyloid beta (Aβ) , tau pathology, AD disease progression and worsened outcomes 12 .

Downregulation of normal ACE2 and increased expression of ACE2 isoforms lacking 39 catalytic-activity could establish hyperactive ACE-Ang-II-AT1R signalling in AD 12 and 40 COVID-19 13 .

To implement preoperative strategies to alleviate neurological consequences of 42 one must propose pathophysiological models that link COVID-19 with AD and PND. 7 We 43 postulate two such pathways that may be triggered by SARS-CoV-2-induced epithelial-44 endothelial cross-talk 13 and inflammation (Fig. 1) .

46 SARS-CoV-2 infection in nasal and olfactory epithelium produces ACE2 downregulation with upregulation of proinflammatory cytokines, establishing high local expression of ACE 48 and Ang-II 13 . From the olfactory epithelium, Ang-II can diffuse transmucosally to produce high concentrations in the olfactory bulb, prefrontal cortex and hippocampus 14 ; these are 50 brain regions with high expression of Ang-1 receptors (AT1Rs). 15 Hence, high Ang-II 51 mediated activity in SARS-CoV-2 could be a mechanism for hippocampal neurotoxicity. 

coronavirus 2; PND, perioperative neurocognitive disorders

ACE2, angiotensin converting 222 enzyme 2

3-HK, 3-hydroxykynurenine; QUIN, 224 quinolinic acid; COVID-19, coronavirus disease 2019; KYNA, kynurenic acid; XA, 225 xanthurenic acid; BBB, blood-brain barrier; CNS, central nervous system; mtROS, 226 mitochondrial radical oxygen species

INF-γ, 227 interferon gamma; TNF-α, tumour necrosis factor alpha; NAD+, nicotinamide adenine 228 dinucleotide plus; OB, olfactory bulb; CP, cribriform plate; LP, lamina propria; OE, olfactory 229 epithelium